血清內(nèi)ALT、LSR及NLR對胃腸間質(zhì)瘤患者病情分級及臨床預(yù)后的影響
[摘要] 目的 探討血清內(nèi)ALT、LSR及NLR對胃腸間質(zhì)瘤(GIST)病情分級及臨床預(yù)后的影響。 方法 選取2016年1月至2017年12月張家港市第一人民醫(yī)院收治的GIST患者82例,根據(jù)病情分級進(jìn)行分組,比較不同病情分級GIST患者ALT、LSR及NLR水平,并研究各指標(biāo)對患者預(yù)后的影響。 結(jié)果 中危組、高危組ALT、LSR及NLR水平均顯著高于極低危組和低危組,高危組ALT、LSR及NLR水平均顯著高于中危組(P
[關(guān)鍵詞] 胃腸間質(zhì)瘤;ALT;LSR;NLR;病情分級;臨床預(yù)后
[中圖分類號] R735.2 [文獻(xiàn)標(biāo)識碼] B [文章編號] 1673-9701(2022)04-0047-05
[Abstract] Objective To explore the influence of serum ALT, LSR and NLR on the disease grading and clinical prognosis of patients with gastrointestinal stromal tumor(GIST). Methods Eighty-two patients with GIST in the First People′s Hospital of Zhangjiagang from January 2016 to December 2017 were selected and they were divided into different groups according to their disease grading. The ALT, LSR and NLR levels of GIST patients with different disease grading were compared, and the influence of each index on the prognosis of patients was studied. Results The levels of ALT, LSR and NLR in middle-risk group and high-risk group were significantly higher than those in extremely low-risk group and low-risk group, while the levels of ALT, LSR and NLR in high-risk group were significantly higher than those in middle-risk group (P
[Key words] Gastrointestinal stromal tumor; ALT; LSR; NLR; Disease grading; Clinical prognosis
肝臟是胃腸道間質(zhì)瘤(gastrointestinal stromal tumor,GIST)的主要轉(zhuǎn)移器官,而血清丙氨酸氨基轉(zhuǎn)移酶(alamine aminotransferase,ALT)和天冬氨酸氨基轉(zhuǎn)移酶(aspartate transaminase,AST)均是臨床評估肝功能的常用指標(biāo)[1]。(剩余5694字)
-
-
- 中國現(xiàn)代醫(yī)生
- 2022年04期
- 丙泊酚調(diào)控HIF-1α表達(dá)靶向...
- 基于Oncomine數(shù)據(jù)庫薈萃...
- 尿道板縱切卷管尿道成形術(shù)和橫形...
- 穩(wěn)定期COPD患者呼出氣一氧化...
- 低頻重復(fù)經(jīng)顱磁刺激治療癲癇的療...
- 非小細(xì)胞肺癌發(fā)生淋巴結(jié)轉(zhuǎn)移風(fēng)險...
- 穴位貼敷療法聯(lián)合磺達(dá)肝癸鈉預(yù)防...
- 甲狀旁腺全切除聯(lián)合前臂自體移植...
- miR-30b在子宮內(nèi)膜異位癥...
- 適用于線粒體基因組測序的高純度...
- 維持性血液透析患者靜脈導(dǎo)管相關(guān)...
- 血清內(nèi)ALT、LSR及NLR對...
- 血壓變異性對老年血液透析患者認(rèn)...
- 胺碘酮治療急性心肌梗死伴心房顫...
- 非體外循環(huán)冠狀動脈旁路移植術(shù)對...
- 多烯磷脂酰膽堿聯(lián)合地塞米松治療...
- 自制中藥凝膠劑在產(chǎn)后子宮復(fù)舊不...
- 纖維支氣管鏡在小兒肺炎支原體肺...
- 兒童肱骨髁上骨折閉合復(fù)位兩種克...
- 外周血內(nèi)NLR和PLR對結(jié)腸癌...
- 中心靜脈胸腔內(nèi)置管持續(xù)引流治療...
- 團(tuán)體心理治療對精神分裂癥后抑郁...
- 基于“動靜平衡”理念的功能訓(xùn)練...
- 頸動脈內(nèi)膜剝脫術(shù)后發(fā)生并發(fā)癥的...
- 酒精性肝損傷患者采用還原型谷胱...
- 體質(zhì)量指數(shù)與圍手術(shù)期頸椎后路單...
- ICU內(nèi)科危重癥患者腸內(nèi)營養(yǎng)喂...
- 胸腔積液和外周血T-SPOT....
- 冠心寧方聯(lián)合常規(guī)西藥對系統(tǒng)性紅...
- 莫西沙星聯(lián)合頭孢哌酮鈉舒巴坦鈉...
- 莫匹羅星軟膏對拔甲術(shù)后傷口愈合...
- 4D-CT與MR-T2圖像在肝...
- 不同無創(chuàng)性檢查方法在慢性乙型肝...
- 羅哌卡因復(fù)合舒芬太尼在剖宮產(chǎn)麻...
- 無肌松藥麻醉用于小兒腺樣體及扁...
- 伴大汗腺分化的乳腺癌臨床病理特...
- 加味柴胡桂枝湯聯(lián)合草酸艾司西酞...
- 基于杠桿定位手法對青少年特發(fā)性...
- 雙柏散外敷治療急性痛風(fēng)性關(guān)節(jié)炎...
- 贛州市2017—2019年無償...
- 寧波市江北區(qū)三年內(nèi)原發(fā)性青光眼...
- 改良床旁教學(xué)法在護(hù)理學(xué)臨床帶教...
- 我院合理用藥系統(tǒng)高危藥品知識庫...
- 以副腫瘤風(fēng)濕綜合征為首發(fā)表現(xiàn)的...
- 食管癌術(shù)后吻合口瘺上消化道X線...
- 基于隨癥采集法的中醫(yī)護(hù)理在腰椎...
- 腦卒中后尿失禁患者功能獨立性水...
- 以Caprini風(fēng)險評估為基礎(chǔ)...
- 加速康復(fù)外科在斜外側(cè)腰椎椎體間...
- 老年2型糖尿病患者夜間低血糖預(yù)...